Pharma’s Blind Spot: How AI Citation Sources Are Reshaping Drug Brand Risk
When a patient asks ChatGPT whether Ozempic causes pancreatitis, the answer they receive depends entirely on which sources the model […]
When a patient asks ChatGPT whether Ozempic causes pancreatitis, the answer they receive depends entirely on which sources the model […]
There are two kinds of “dependency” in medicine. One is the obvious sort—people miss a dose and feel terrible. The
No pharmaceutical brand team sets a quarterly target for off-label prescriptions. Nobody puts “unauthorized use growth” on a slide for
Alcohol is the universal solvent. It dissolves inhibitions, plans, and—sometimes—drug safety. If you’re taking prescription medicines (especially the ones that
In 2023, a 54-year-old woman in Phoenix typed a question into ChatGPT that her endocrinologist hadn’t fully answered to her
When a physician in Ohio types “best GLP-1 for weight loss” into Perplexity and receives a two-paragraph synthesis with no
ChatGPT has told patients that Ozempic is FDA-approved for weight loss in children. Gemini has cited drug interaction warnings that
A patient asks ChatGPT whether their antidepressant can help with chronic pain. Another asks Gemini if a GLP-1 drug will
When a patient types “is Ozempic safe for someone with a history of pancreatitis?” into ChatGPT, they get an answer
Most pharmaceutical companies still don’t know what ChatGPT says about their drugs. They don’t know whether Perplexity recommends their biologic
Three vendors control most of the case-processing market that keeps adverse event reports moving from intake to FDA submission. Oracle
Drug switching is supposed to be boring: same active ingredient, same job, fewer surprises. But in the real world, “brand
Sign in or create a free account to read this DrugChatter article